22.7 C
London
Wednesday, July 6, 2022

2022-0319 – New Listing – Nirvana Life Sciences Inc. (NIRV)

The common shares of Nirvana Life Sciences Inc., have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.

The Exchange is accepting Market Maker applications for NIRV. Please email: Trading@theCSE.com

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Source

Source link

Related Articles

Latest Articles